Multipotent mesenchymal stem cells in renal transplantation

Kidney transplantation is the most effective treatment for the end-stage chronic renal disease that has been observed to increase in the incidence consistently in recent years. Despite the achievements in immunosuppressive therapy in patients after renal transplantation, the graft survival length ha...

Full description

Saved in:
Bibliographic Details
Main Authors: N. V. Borovkova, M. Sh. Khubutiya, O. N. Rzhevskaya, A. V. Pinchuk, D. A. Vasil’chenkov
Format: Article
Language:English
Published: N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department 2019-03-01
Series:Трансплантология (Москва)
Subjects:
Online Access:https://www.jtransplantologiya.ru/jour/article/view/419
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849252585042608128
author N. V. Borovkova
M. Sh. Khubutiya
O. N. Rzhevskaya
A. V. Pinchuk
D. A. Vasil’chenkov
author_facet N. V. Borovkova
M. Sh. Khubutiya
O. N. Rzhevskaya
A. V. Pinchuk
D. A. Vasil’chenkov
author_sort N. V. Borovkova
collection DOAJ
description Kidney transplantation is the most effective treatment for the end-stage chronic renal disease that has been observed to increase in the incidence consistently in recent years. Despite the achievements in immunosuppressive therapy in patients after renal transplantation, the graft survival length has remained unchangeable during the recent few decades. Bone marrow multipotent mesenchymal (stromal) stem cells (BM MMSCs) are known as a potential tool to influence this situation. Since their discovery in the middle of the XX century, their wide therapeutic potential in the transplantation of solid organs was demonstrated both in experimental and clinical trials. They have the ability to modify recipient’s immune response and improve postoperative course, however, having a low level of their own immunogenicity. MMSCs realize their properties through interactions both with the innate and adoptive immune system. Meanwhile, actual questions such as an optimal dosage and injection timing are still need answers. Actual experience of both experimental and clinical use of MMSCs in kidney transplantation has been analyzed in the present publication.
format Article
id doaj-art-ef56c6e6c2554b3ea8ca2807dd266afa
institution Kabale University
issn 2074-0506
2542-0909
language English
publishDate 2019-03-01
publisher N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department
record_format Article
series Трансплантология (Москва)
spelling doaj-art-ef56c6e6c2554b3ea8ca2807dd266afa2025-08-20T03:56:36ZengN.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare DepartmentТрансплантология (Москва)2074-05062542-09092019-03-01111213610.23873/2074-0506-2019-11-1-21-36398Multipotent mesenchymal stem cells in renal transplantationN. V. Borovkova0M. Sh. Khubutiya1O. N. Rzhevskaya2A. V. Pinchuk3D. A. Vasil’chenkov4N.V. Sklifosovsky Research Institute for Emergency MedicineN.V. Sklifosovsky Research Institute for Emergency MedicineN.V. Sklifosovsky Research Institute for Emergency MedicineN.V. Sklifosovsky Research Institute for Emergency MedicineA.I. Yevdokimov Moscow State University of Medicine and DentistryKidney transplantation is the most effective treatment for the end-stage chronic renal disease that has been observed to increase in the incidence consistently in recent years. Despite the achievements in immunosuppressive therapy in patients after renal transplantation, the graft survival length has remained unchangeable during the recent few decades. Bone marrow multipotent mesenchymal (stromal) stem cells (BM MMSCs) are known as a potential tool to influence this situation. Since their discovery in the middle of the XX century, their wide therapeutic potential in the transplantation of solid organs was demonstrated both in experimental and clinical trials. They have the ability to modify recipient’s immune response and improve postoperative course, however, having a low level of their own immunogenicity. MMSCs realize their properties through interactions both with the innate and adoptive immune system. Meanwhile, actual questions such as an optimal dosage and injection timing are still need answers. Actual experience of both experimental and clinical use of MMSCs in kidney transplantation has been analyzed in the present publication.https://www.jtransplantologiya.ru/jour/article/view/419bone marrow multipotent mesenchymal stem cellsrenal transplantationtoleranceimmunosuppressionrecipientrejectionimmune responseinflammationregenerationimmunogenicity
spellingShingle N. V. Borovkova
M. Sh. Khubutiya
O. N. Rzhevskaya
A. V. Pinchuk
D. A. Vasil’chenkov
Multipotent mesenchymal stem cells in renal transplantation
Трансплантология (Москва)
bone marrow multipotent mesenchymal stem cells
renal transplantation
tolerance
immunosuppression
recipient
rejection
immune response
inflammation
regeneration
immunogenicity
title Multipotent mesenchymal stem cells in renal transplantation
title_full Multipotent mesenchymal stem cells in renal transplantation
title_fullStr Multipotent mesenchymal stem cells in renal transplantation
title_full_unstemmed Multipotent mesenchymal stem cells in renal transplantation
title_short Multipotent mesenchymal stem cells in renal transplantation
title_sort multipotent mesenchymal stem cells in renal transplantation
topic bone marrow multipotent mesenchymal stem cells
renal transplantation
tolerance
immunosuppression
recipient
rejection
immune response
inflammation
regeneration
immunogenicity
url https://www.jtransplantologiya.ru/jour/article/view/419
work_keys_str_mv AT nvborovkova multipotentmesenchymalstemcellsinrenaltransplantation
AT mshkhubutiya multipotentmesenchymalstemcellsinrenaltransplantation
AT onrzhevskaya multipotentmesenchymalstemcellsinrenaltransplantation
AT avpinchuk multipotentmesenchymalstemcellsinrenaltransplantation
AT davasilchenkov multipotentmesenchymalstemcellsinrenaltransplantation